piperazine has been researched along with diamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Budde, T; Füsser, F; Grey, L; Heitman, LH; Hundehege, P; Isaak, A; Junker, A; Koch, O; Michetti, L; Ortiz Zacarías, NV; Patberg, M; Schulte, J; van der Horst, C; Vinnenberg, L | 1 |
1 other study(ies) available for piperazine and diamide
| Article | Year |
|---|---|
Piperazine squaric acid diamides, a novel class of allosteric P2X7 receptor antagonists.
Topics: Cyclobutanes; Diamide; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Molecular Structure; Piperazine; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |